CID 3043475

4-morpholineacetamide, n-phenyl-n-(2-(p-tolyloxy)ethyl)-, hydrochloride

Structural Information

Molecular Formula
C21H26N2O3
SMILES
CC1=CC=C(C=C1)OCCN(C2=CC=CC=C2)C(=O)CN3CCOCC3
InChI
InChI=1S/C21H26N2O3/c1-18-7-9-20(10-8-18)26-16-13-23(19-5-3-2-4-6-19)21(24)17-22-11-14-25-15-12-22/h2-10H,11-17H2,1H3
InChIKey
YQKWZNIGKJWHCS-UHFFFAOYSA-N
Compound name
N-[2-(4-methylphenoxy)ethyl]-2-morpholin-4-yl-N-phenylacetamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

354.19434 Da
Monoisotopic Mass

3.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 355.201616 186.8
[M+Na]+ 377.183558 188.5
[M-H]- 353.187064 195.2
[M+NH4]+ 372.228163 195.9
[M+K]+ 393.157498 186.8
[M+H-H2O]+ 337.191600 175.4
[M+HCOO]- 399.192541 204.8
[M+CH3COO]- 413.208191 217.5
[M+Na-2H]- 375.169006 189.1
[M]+ 354.19379142 186.0
[M]- 354.19488858 186.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.